Evidence map›Paper›PMID 38078834›Full record

ArticleJornal brasileiro de nefrologia

Brazilian Dialysis Survey 2022.

Fabiana Baggio Nerbass, Helbert do Nascimento Lima, José Andrade Moura-Neto, Jocemir Ronaldo Lugon, Ricardo Sesso

Abstract read
In one paragraph

Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Brazilian Guidelines of Hypertension - 2025.Arquivos brasileiros de cardiologia · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fabiana Baggio NerbassFundação Pró-Rim, Joinville, SC, Brazil.ORCID http://orcid.org/0000-0001-9936-0185
Helbert do Nascimento LimaUniversidade da Região de Joinville, Joinville, SC, Brazil.ORCID http://orcid.org/0000-0003-0081-6897
José Andrade Moura-NetoEscola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil.ORCID http://orcid.org/0000-0003-1339-3731
Jocemir Ronaldo LugonUniversidade Federal Fluminense, Niterói, RJ, Brazil.ORCID http://orcid.org/0000-0001-6791-3910
Ricardo SessoUniversidade Federal de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-1062-0073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Brazilian Dialysis Survey (BDS) is an annual national survey about patients on chronic dialysis that contributes to health policies.

objectiveTo report the 2022 epidemiological data from the BDS of the Brazilian Society of Nephrology (BSN).

methodsA survey was carried out in Brazilian chronic dialysis centers using an online questionnaire that included clinical and epidemiological aspects of patients on chronic dialysis, dialysis therapy data, and dialysis center characteristics.

resultsOverall, 28% (n = 243) of the centers answered the questionnaire. In July 2022, the estimated total number of patients on dialysis was 153,831. The estimated prevalence and incidence rates of patients per million population (pmp) were 758 and 214, respectively. Of the prevalent patients, 95.3% were on hemodialysis (HD, 4.6% of these on hemodiafiltration) and 4.7% on peritoneal dialysis (PD). Only 1.3% of patients were not vaccinated against COVID-19. The prevalence of anemia (Hb < 10g/dL) was 27% and hyperphosphatemia (P > 5.5mg/dL) reached 30%. The estimated overall crude annual mortality rate was 17.1%.

conclusionsThe absolute number and prevalence rate of patients on chronic dialysis continue to increase. A growing number of patients were receiving hemodiafiltration. The mortality rate decreased, probably due to the end of COVID-19 pandemic. The conclusions were drawn in the context of relatively low voluntary participation, which imposed methodological limitations on our estimates.

Indexed as

Kidney Failure, ChronicPeritoneal DialysisBrazilHumansPandemicsRenal DialysisSurveys and Questionnaires

Identifiers

PMID38078834
PMCPMC11210532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.